Publications by authors named "Peter McLaughlin"

Claim this Profile
N
Neuroscience explanations really do satisfy: A systematic review and meta-analysis of the seductive allure of neuroscience.
Elizabeth M Bennett, Peter J McLaughlin

Public Underst Sci· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Investigation of Ionization Potential in Quantum Dots Using the Stratified Stochastic Enumeration of Molecular Orbitals Method.
Nicole Spanedda, Peter F McLaughlin, Jessica J Beyer, Arindam Chakraborty

J Chem Theory Comput· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Not Available].
Mathias Grote, Anke Te Heesen, Peter McLaughlin, Hans-Jörg Rheinberger

Ber Wiss· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Software for the frontiers of quantum chemistry: An overview of developments in the Q-Chem 5 package.
Evgeny Epifanovsky, Andrew T B Gilbert, Xintian Feng, Joonho Lee, Yuezhi Mao, Peter F McLaughlin

J Chem Phys· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Muscarinic M1, but not M4, receptor antagonism impairs divided attention in male rats.
Paige R Nicklas, Miranda L Kiefer, Mikaela A Whalen, Maeve T Stewart, Deandra E Mosura, Peter J McLaughlin

Pharmacol Biochem Behav· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Monitoring the composition, authenticity and quality dynamics of commercially available Nigerian fat-filled milk powders under inclement conditions using NIRS, chemometrics, packaging and microbiological parameters.
Kizito Kene Ejeahalaka, Peter Mclaughlin, Stephen L W On

Food Chem· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Initial report of a phase II study with R-FND followed by ibritumomab tiuxetan radioimmunotherapy and rituximab maintenance in patients with untreated high-risk follicular lymphoma.
Felipe Samaniego, Peter McLaughlin, Sattva S Neelapu, Lei Feng, Michelle Fanale

Leuk Lymphoma· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Compact Real-Space Representation of Excited States Using Frequency-Dependent Explicitly Correlated Electron-Hole Interaction Kernel.
Peter F McLaughlin, Arindam Chakraborty

J Chem Theory Comput· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Decoupling and Coupling of the Host-Dopant Interaction by Manipulating Dopant Movement in Core/Shell Quantum Dots.
Elan Hofman, Alex Khammang, Joshua T Wright, Zhi-Jun Li, Peter Francis McLaughlin

J Phys Chem Lett· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biphasic effects of 5-HT agonism on impulsive responding are dissociable from effects on anxiety in the variable consecutive number task.
Miranda L Groft, Marigny C Normann, Paige R Nicklas, Julia E Jagielo-Miller, Peter J McLaughlin

Naunyn Schmiedebergs Arch Pharmacol· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term overall- and progression-free survival after pentostatin, cyclophosphamide and rituximab therapy for indolent non-Hodgkin lymphoma.
Tamer Khashab, Fredrick Hagemeister, Jorge E Romaguera, Michelle A Fanale, Barbara Pro, Peter McLaughlin

Br J Haematol· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 2 trial of bortezomib in combination with rituximab plus hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone alternating with bortezomib, rituximab, methotrexate, and cytarabine for untreated mantle cell lymphoma.
Jorge E Romaguera, Michael Wang, Lei Feng, Luis E Fayad, Frederick Hagemeister, Peter McLaughlin

Cancer· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of the timing of hepatitis B virus identification and anti-hepatitis B virus therapy initiation on the risk of adverse liver outcomes for patients receiving cancer therapy.
Jessica P Hwang, Maria E Suarez-Almazor, Scott B Cantor, Andrea Barbo, Heather Y Lin, Peter McLaughlin

Cancer· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Encouraging activity for R-CHOP in advanced stage nodular lymphocyte-predominant Hodgkin lymphoma.
Michelle A Fanale, Chan Yoon Cheah, Amy Rich, L Jeffrey Medeiros, Chao-Ming Lai, Peter McLaughlin

Blood· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High ten-year remission rates following rituximab, fludarabine, mitoxantrone and dexamethasone (R-FND) with interferon maintenance in indolent lymphoma: Results of a randomized Study.
Loretta J Nastoupil, Peter McLaughlin, Lei Feng, Sattva S Neelapu, Felipe Samaniego

Br J Haematol· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Premature closure of a phase II study of bendamustine, mitoxantrone and rituximab for patients with untreated high-risk follicular lymphoma due to severe haematological and infectious toxicity.
Chan Y Cheah, Loretta J Nastoupil, Peter McLaughlin, Michelle A Fanale, Sattva S Neelapu

Br J Haematol· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic significance of baseline peripheral absolute neutrophil, monocyte and serum β2-microglobulin level in patients with diffuse large b-cell lymphoma: a new prognostic model.
Yiming Chen, Sattva Neelapu, Lei Feng, Weiqi Bi, Tian-Hui Yang, Peter McLaughlin

Br J Haematol· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CB1 antagonism produces behaviors more consistent with satiety than reduced reward value in food-maintained responding in rats.
Emily E Thompson, Julia E Jagielo-Miller, V Kiran Vemuri, Alexandros Makriyannis, Peter J McLaughlin

J Psychopharmacol· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stage I-II follicular lymphoma: an endangered species?
Peter McLaughlin, John F Seymour

Leuk Lymphoma· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nontypeable Haemophilus influenzae induces sustained lung oxidative stress and protease expression.
Paul T King, Roleen Sharma, Kim O'Sullivan, Stavros Selemidis, Steven Lim, Peter McLaughlin

PLoS One· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rituximab plus hyper-CVAD alternating with MTX/Ara-C in patients with newly diagnosed mantle cell lymphoma: 15-year follow-up of a phase II study from the MD Anderson Cancer Center.
Dai Chihara, Chan Y Cheah, Jason R Westin, Luis E Fayad, Maria A Rodriguez, Peter McLaughlin

Br J Haematol· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II study of HCVIDD/MA in patients with newly diagnosed peripheral T-cell lymphoma.
Dai Chihara, Barbara Pro, Sanam Loghavi, Roberto N Miranda, L Jeffrey Medeiros, Peter McLaughlin

Br J Haematol· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pentostatin, cyclophosphamide and rituximab for previously untreated advanced stage, low-grade B-cell lymphomas.
Felipe Samaniego, Fredrick Hagemeister, Jorge E Romaguera, Michelle A Fanale, Barbara Pro, Peter McLaughlin

Br J Haematol· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A case of recurrent pneumonia and lung abscess in an immunocompetent patient.
A K M Nizam Uddin, Peter McLaughlin, Darren Mansfield, Kenneth Lau

BMJ Case Rep· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis